Skip Nav Destination
Issues
1 January 2022
-
Cover Image
Cover Image
The Hallmarks of Cancer provides a set of underlying principles to explain the mechanisms of malignant tumor formation and cancer progression. Originally including six hallmarks, the framework was later expanded to encompass four new features. Now, a decade later, new insights stemming from a deeper understanding of cancer and its diversity necessitate the prospective addition of several new hallmarks. These include “unlocking phenotypic plasticity,” “nonmutational epigenetic reprogramming,” “polymorphic microbiomes,” and “senescent cells.” To read more, see the review “Hallmarks of Cancer: New Additions” by Hanahan on page 31.Close Modal - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 2159-8274
EISSN 2159-8290
Issue Sections
In This Issue
In the Spotlight
Science in Society
Review
Research Brief
Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC
Kwan Ho Tang; Shuai Li; Alireza Khodadadi-Jamayran; Jayu Jen; Han Han; Kayla Guidry; Ting Chen; Yuan Hao; Carmine Fedele; John A. Zebala; Dean Y. Maeda; James G. Christensen; Peter Olson; Argus Athanas; Cynthia A. Loomis; Aristotelis Tsirigos; Kwok-Kin Wong; Benjamin G. Neel
Research Articles
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer
Pasi A. Jänne; Christina Baik; Wu-Chou Su; Melissa L. Johnson; Hidetoshi Hayashi; Makoto Nishio; Dong-Wan Kim; Marianna Koczywas; Kathryn A. Gold; Conor E. Steuer; Haruyasu Murakami; James Chih-Hsin Yang; Sang-We Kim; Michele Vigliotti; Rong Shi; Zhenhao Qi; Yang Qiu; Lihui Zhao; David Sternberg; Channing Yu; Helena A. Yu
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
Claudio Vernieri; Giovanni Fucà; Francesca Ligorio; Veronica Huber; Andrea Vingiani; Fabio Iannelli; Alessandra Raimondi; Darawan Rinchai; Gianmaria Frigè; Antonino Belfiore; Luca Lalli; Claudia Chiodoni; Valeria Cancila; Federica Zanardi; Arta Ajazi; Salvatore Cortellino; Viviana Vallacchi; Paola Squarcina; Agata Cova; Samantha Pesce; Paola Frati; Raghvendra Mall; Paola Antonia Corsetto; Angela Maria Rizzo; Cristina Ferraris; Secondo Folli; Marina Chiara Garassino; Giuseppe Capri; Giulia Bianchi; Mario Paolo Colombo; Saverio Minucci; Marco Foiani; Valter Daniel Longo; Giovanni Apolone; Valter Torri; Giancarlo Pruneri; Davide Bedognetti; Licia Rivoltini; Filippo de Braud
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
Fernanda G. Herrera; Catherine Ronet; Maria Ochoa de Olza; David Barras; Isaac Crespo; Massimo Andreatta; Jesus Corria-Osorio; Aodrenn Spill; Fabrizio Benedetti; Raphael Genolet; Angela Orcurto; Martina Imbimbo; Eleonora Ghisoni; Blanca Navarro Rodrigo; Dominik R. Berthold; Apostolos Sarivalasis; Khalil Zaman; Rafael Duran; Clarisse Dromain; John Prior; Niklaus Schaefer; Jean Bourhis; Georgia Dimopoulou; Zoi Tsourti; Marius Messemaker; Thomas Smith; Sarah E. Warren; Periklis Foukas; Sylvie Rusakiewicz; Mikaël J. Pittet; Stefan Zimmermann; Christine Sempoux; Urania Dafni; Alexandre Harari; Lana E. Kandalaft; Santiago J. Carmona; Denarda Dangaj Laniti; Melita Irving; George Coukos
Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level
Yingcheng Wu; Shuaixi Yang; Jiaqiang Ma; Zechuan Chen; Guohe Song; Dongning Rao; Yifei Cheng; Siyuan Huang; Yifei Liu; Shan Jiang; Jinxia Liu; Xiaowu Huang; Xiaoying Wang; Shuangjian Qiu; Jianmin Xu; Ruibin Xi; Fan Bai; Jian Zhou; Jia Fan; Xiaoming Zhang; Qiang Gao
Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis
Maximilian O. Schaettler; Megan M. Richters; Anthony Z. Wang; Zachary L. Skidmore; Bryan Fisk; Katherine E. Miller; Tammi L. Vickery; Albert H. Kim; Michael R. Chicoine; Joshua W. Osbun; Eric C. Leuthardt; Joshua L. Dowling; Gregory J. Zipfel; Ralph G. Dacey; Hsiang-Chih Lu; Tanner M. Johanns; Obi L. Griffith; Elaine R. Mardis; Malachi Griffith; Gavin P. Dunn
PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia
Jianping Li; Julia Hlavka-Zhang; Jonathan H. Shrimp; Crissandra Piper; Daphne Dupéré-Richér; Jacob S. Roth; Duohui Jing; Heidi L. Casellas Román; Catalina Troche; Alok Swaroop; Marta Kulis; Jon A. Oyer; Christine M. Will; Min Shen; Alberto Riva; Richard L. Bennett; Adolfo A. Ferrando; Matthew D. Hall; Richard B. Lock; Jonathan D. Licht
RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy
Kyung W. Song; Kyle A. Edgar; Emily J. Hanan; Marc Hafner; Jason Oeh; Mark Merchant; Deepak Sampath; Michelle A. Nannini; Rebecca Hong; Lilian Phu; William F. Forrest; Eric Stawiski; Stephen Schmidt; Nicholas Endres; Jane Guan; Jeffrey J. Wallin; Jonathan Cheong; Emile G. Plise; Gail D. Lewis Phillips; Laurent Salphati; Timothy P. Heffron; Alan G. Olivero; Shiva Malek; Steven T. Staben; Donald S. Kirkpatrick; Anwesha Dey; Lori S. Friedman
Systematic Profiling of DNMT3A Variants Reveals Protein Instability Mediated by the DCAF8 E3 Ubiquitin Ligase Adaptor
Yung-Hsin Huang; Chun-Wei Chen; Venkatasubramaniam Sundaramurthy; Mikołaj Słabicki; Dapeng Hao; Caroline J. Watson; Ayala Tovy; Jaime M. Reyes; Olga Dakhova; Brielle R. Crovetti; Christina Galonska; Minjung Lee; Lorenzo Brunetti; Yubin Zhou; Katrina Tatton-Brown; Yun Huang; Xiaodong Cheng; Alexander Meissner; Peter J.M. Valk; Lionel Van Maldergem; Mathijs A. Sanders; Jamie R. Blundell; Wei Li; Benjamin L. Ebert; Margaret A. Goodell
News in Brief
Research Watch
Tumorigenesis
Metastasis
Hematopoiesis
Metabolism
Glioma
Immunology
Targeted Therapy
Immunotherapy
Lymphoma
Clinical Trials
Drug Resistance
Structural Biology
Glioblastoma
Pancreatic Cancer
Leukemia
Oncogenes
Acknowledgment to Reviewers
Advertisement